The focus of Project 2 of this Program Project is to confinue to pursue approaches to culfivate human caliciviruses and to understand the molecular basis of restricfion of virus gene expression, replicafion and growth in cell systems. Although the clinical and economic significance of the human noroviruses as the most important cause of global foodborne and waterborne illness is now recognized, factors affecting the persistence and transmission of viable virus in the environment and the underlying mechanisms of pathogenesis and immunity are poorly understood. This lack of understanding is largely due to the lack of available in vitro culfivafion or animal models of infecfion. Our long-term goal is to exploit fundamental discoveries made in the previous project period that can measure in vitro infectivity and new in vitro cell culture systems for gastrointesfinal epithelium.
In Specific Aim 1, we will improve and develop efficient in vitro methods for culfivafion of Norwalk virus and other noroviruses. Studies in this aim will determine if the restriction of viral spread in RNA-transfected cells is due to the lack of a co-receptor. These studies will also exploit new ideas to obtain and maintain primary human intesfinal epithelial cells in culture.
In Specific Aim 2, we propose to understand the molecular mechanisms by which norovirus protein expression regulates cellular innate responses as well as whether these cellular responses regulate viral replicafion and spread.
In Specific Aim 3, we propose to use gene expression and replicafion systems to dissect the mechanisms by which VPl, VP2, and VPg interact with each other and with genomic RNA for RNA encapsidation. The results from these studies will generate new knowledge about the replicafion of noroviruses and will complement and allow funcfional assessment of methods of virus detection as well as of antivirals that are developed in Projects 1 and 3.
The proposed studies address the single largest challenge in studying noroviruses - the lack of efficient in vitro culfivafion systems. Understanding the basis for host restriction of norovirus replicafion will lead the way for successful virus cultivafion, as well as faciliate demonstration of effecfiveness of antivirals, development of rapid diagnosfic assays and evaluation of whether correlates of protective immunity exist
|Hurwitz, Amy M; Huang, Wanzhi; Estes, Mary K et al. (2017) Deep sequencing of phage-displayed peptide libraries reveals sequence motif that detects norovirus. Protein Eng Des Sel 30:129-139|
|Yu, Huimin; Hasan, Nesrin M; In, Julie G et al. (2017) The Contributions of Human Mini-Intestines to the Study of Intestinal Physiology and Pathophysiology. Annu Rev Physiol 79:291-312|
|Ramani, Sasirekha; Neill, Frederick H; Ferreira, Jennifer et al. (2017) B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine. Clin Vaccine Immunol 24:|
|Cortes-Penfield, Nicolas W; Ramani, Sasirekha; Estes, Mary K et al. (2017) Prospects and Challenges in the Development of a Norovirus Vaccine. Clin Ther 39:1537-1549|
|Zou, Winnie Y; Blutt, Sarah E; Crawford, Sue E et al. (2017) Human Intestinal Enteroids: New Models to Study Gastrointestinal Virus Infections. Methods Mol Biol :|
|Shanker, Sreejesh; Hu, Liya; Ramani, Sasirekha et al. (2017) Structural features of glycan recognition among viral pathogens. Curr Opin Struct Biol 44:211-218|
|Hurwitz, Amy M; Huang, Wanzhi; Kou, Baijun et al. (2017) Identification and Characterization of Single-Chain Antibodies that Specifically Bind GI Noroviruses. PLoS One 12:e0170162|
|Foulke-Abel, Jennifer; In, Julie; Yin, Jianyi et al. (2016) Human Enteroids as a Model of Upper Small Intestinal Ion Transport Physiology and Pathophysiology. Gastroenterology 150:638-649.e8|
|Mills, Melody; Estes, Mary K (2016) Physiologically relevant human tissue models for infectious diseases. Drug Discov Today 21:1540-1552|
|Shanker, Sreejesh; Czakó, Rita; Sapparapu, Gopal et al. (2016) Structural basis for norovirus neutralization by an HBGA blocking human IgA antibody. Proc Natl Acad Sci U S A 113:E5830-E5837|
Showing the most recent 10 out of 94 publications